Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca Licenses Protherics Sepsis Treatment

Dec 08 2005

• By Bowman Cox

Related Content

Eisai Preps Eritoran For Phase III Sepsis Trial Based On Phase II Mortality Reduction

Aug 29 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window